The innervation of cerebral blood vessels by nerve fibers containing calcitonin gene-related peptide (CGRP) and the vasomotor effects of this peptide are de scribed for a number of different mammalian species. CGRP-immunoreactive nerve fibers were present in the adventitia of cerebral arteries in all species examined (guinea pig, cat, rabbit, rat, and mouse). Numerous peri karya containing CGRP immunoreactivity are demon strable in the trigeminal ganglion of all species. In the cerebral perivascular nerve fibers and in trigeminal peri karya, CGRP is often colocalized with substance P and neurokinin A. Marked interspecies differences exist both in the density of CGRP-immunoreactive nerve fibers and in the cerebrovascular levels measured with radioimmu noassay. The highest concentrations were observed in ce rebral vessels from guinea pigs, the lowest concentration in rabbit vessels, and intermediate levels in the feline and human cerebral vasculature. CGRP is a potent dilator of Calcitonin gene-related peptide (CGRP) is a 37 amino acid peptide recently identified from struc tural analysis of the products of calcitonin gene ex pression (Amara et al., 1982; Rosenfeld et al. , 1983) . CGRP-immunoreactive fibers are abundant in the sensory receiving areas of the spinal cord and to a lesser extent in the sympathetic and parasym pathetic centers. CGRP-containing terminals are also present in sensory nuclei of the lower brain stem, for example, the nucleus tractus solitarius (Gibson et aI. , 1984; Kawai et aI., 1985; Skofitsch and Jacobowitz, 1985) . Immunocytochemical studies have revealed that CGRP coexists with sub stance P and neurokinin A in nerve cell bodies of 720 cerebral arteries in all species examined (human pial, fe line middle cerebral, rabbit, guinea pig and rat basilar ar teries). The concentration of CGRP eliciting half-max imal responses ranged from 0.4 nM (human pial artery) to 3 nM (rat and rabbit basilar arteries). Pretreatment of ce rebral arteries with low concentrations of either sub stance P (0.1 nM) or neurokinin A (3 nM) attenuated slightly the CGRP-induced relaxations of guinea pig bas ilar arteries. Calcitonin was found to be a very weak di lator of cerebral arteries from human and guinea pig. Thus, cardiovascular nerve fibers containing CGRP ap pear to be present in all mammalian species (although to varying degrees) and CGRP is invariably a potent dilator of the cerebral arteries for all species.
Summary: The innervation of cerebral blood vessels by nerve fibers containing calcitonin gene-related peptide (CGRP) and the vasomotor effects of this peptide are de scribed for a number of different mammalian species. CGRP-immunoreactive nerve fibers were present in the adventitia of cerebral arteries in all species examined (guinea pig, cat, rabbit, rat, and mouse). Numerous peri karya containing CGRP immunoreactivity are demon strable in the trigeminal ganglion of all species. In the cerebral perivascular nerve fibers and in trigeminal peri karya, CGRP is often colocalized with substance P and neurokinin A. Marked interspecies differences exist both in the density of CGRP-immunoreactive nerve fibers and in the cerebrovascular levels measured with radioimmu noassay. The highest concentrations were observed in ce rebral vessels from guinea pigs, the lowest concentration in rabbit vessels, and intermediate levels in the feline and human cerebral vasculature. CGRP is a potent dilator of Calcitonin gene-related peptide (CGRP) is a 37 amino acid peptide recently identified from struc tural analysis of the products of calcitonin gene ex pression (Amara et al., 1982; Rosenfeld et al. , 1983) . CGRP-immunoreactive fibers are abundant in the sensory receiving areas of the spinal cord and to a lesser extent in the sympathetic and parasym pathetic centers. CGRP-containing terminals are also present in sensory nuclei of the lower brain stem, for example, the nucleus tractus solitarius (Gibson et aI. , 1984; Kawai et aI., 1985; Skofitsch and Jacobowitz, 1985) . Immunocytochemical studies have revealed that CGRP coexists with sub stance P and neurokinin A in nerve cell bodies of cerebral arteries in all species examined (human pial, fe line middle cerebral, rabbit, guinea pig and rat basilar ar teries). The concentration of CGRP eliciting half-max imal responses ranged from 0.4 nM (human pial artery) to 3 nM (rat and rabbit basilar arteries). Pretreatment of ce rebral arteries with low concentrations of either sub stance P (0.1 nM) or neurokinin A (3 nM) attenuated slightly the CGRP-induced relaxations of guinea pig bas ilar arteries. Calcitonin was found to be a very weak di lator of cerebral arteries from human and guinea pig. Thus, cardiovascular nerve fibers containing CGRP ap pear to be present in all mammalian species (although to varying degrees) and CGRP is invariably a potent dilator of the cerebral arteries for all species. Key Words: Cere bral arteries-Calcitonin gene-related peptide-Immu nocytochemistry-Radioimmunoassay-Vasomotor re activity. sensory ganglia (Gibbins et aI. , 1985; Sundler et aI. , 1985) . In the rat and cat trigeminal ganglia, which are known to project to the cerebral vasculature (Mayberg et aI., 1984) , there are numerous CGRP immunoreactive perikarya in which substance P is often colocalized U ddman et aI. , 1985; Gibbins et aI. , 1985; McCulloch et aI., 1986) . Hitherto, CGRP-immunoreactive cerebro vascular nerve fibers have been identified in cats (Hanko et aI., 1985; Uddman et aI., 1985; McCul loch et aI., 1986) and in humans (Edvinsson et aI. , 1987) although there is a preliminary report of CGRP nerves in the guinea pig and rat cerebral vas culature (Mat suyama et aI., 1985) . Significant levels of CGRP have been detected with radioimmuno assay in human pial arteries (Edvinsson et aI. , 1987) . In the present study, we have identified the presence of CGRP nerve fibers in the cerebral vas culature of various mammals, including humans, and demonstrated considerable interspecies differ ences in the levels of cerebrovascular CGRP.
CGRP is a potent dilator of peripheral blood vessels (Brain et al., 1985; Fischer et al., 1983; Uddman et aI., 1986) . However, only in feline cere bral blood vessels have the vasomotor effects of CGRP been systematically studied hitherto (Ed vinsson et aI., 1985; Hanko et aI., 1985; McCulloch et aI., 1986) . In the present study, we describe the vasomotor effects of CGRP and calcitonin in iso lated cerebral arteries from five species.
MATERIALS AND METHODS

Immunocytochemistry
Specimens were obtained from the pia-arachnoid membrane of cat (n = 3), guinea pig (n = 8), rat (n = 6), and mouse (n = 6). Cats were exsanguinated under pen tobarbital anesthesia (Nembutal 30 mg/kg, i.p.). The ro dents were decapitated under diethyl ether anesthesia. In additional guinea pigs, rats, and mice (n = 4 of each), the right superior cervical ganglion was removed 1 week be fore they were killed (Nembutal 30 mg/kg, i.p.). Pial vessels from cats and trigeminal ganglia from rats and guinea pigs were fixed by immersion into a mixture of 15% of a saturated aqueous picric acid solution and 2% formaldehyde, buffered to pH 7.2 with 0.1 M phosphate buffer and thoroughly rinsed for 48 h in a Tyrode solution containing 10% sucrose at 4°C. The specimens were frozen on dry ice and sectioned at 10-J.Lm thickness in a cryostat. In addition, pial vessels from the cerebral con vexity and from the base of the brain, choroid plexus and dura mater of cats, guinea pigs, rats, and mice were stretched flat on chrome-alum subbed microscope slides as whole mounts and fixed in the same fixative as above overnight. The whole mounts were then immersed in a Tyrode solution containing 10% sucrose for 48 h, washed in phosphate buffer, and processed for the immunocyto chemical demonstration of CGRP using an indirect im munofluorescence method (Coons et aI., 1955) .
The CGRP antiserum (code no. 8427; Milab, Malmo, Sweden) was raised in rabbit using a conjugate of syn thetic rat CGRP and bovine serum albumin (Grunditz et aI., 1986) . The CGRP antiserum was used in a dilution of 1: 1280 (cryostat sections) or in a dilution of 1 :640 (whole mounts). In the immunocytochemical studies, the CGRP antiserum was found not to cross-react with substance P or neurokinin A (Sundler et aI., 1985) . The antiserum against substance P (code no. substance P-8; gift from Dr. P. Emson, MRC, Cambridge, U.K.) was raised in a rabbit against protein-conjugated synthetic bovine substance P and used in a dilution of 1 :320. The substance P anti serum does not cross-react with CGRP or neurokinin A. It does, however, cross-react with physalaemin. The tissue sections were exposed to CGRP and substance P antiserum overnight at + 4°C and to fluorescein isothio cyanate-labeled goat antirabbit immunoglobulin G (IgG) (Milab, Malmo, Sweden) for 1 h at room temperature in a dilution of 1:320.
Control sections were incubated with CGRP or sub stance P antiserum inactivated by the addition of excess amounts of antigen (100 J.Lg of synthetic rat CGRP or syn thetic bovine substance P per milliliter diluted of anti-serum). Cross-reactivity with other peptides containing the same or similar immunoreactive sequences cannot be excluded. It is therefore appropriate to refer to the immu noreactive material as CGRP-like or substance P-like. For brevity, however, the immunoreactive material is re ferred to as CGRP and substance P in the text.
In a separate study, sections from the trigeminal gan glion and whole mounts from the pia arachnoid (pro cessed as above) were double stained for CGRP and sub stance P. For this purpose, a commercially available monoclonal substance P antiserum was used (code no. NCI-34; Seralab, U.K.). Specimens were first incubated with the substance P antiserum, diluted 1 :80 from the stock solution, and then with the CGRP antiserum. The monoclonal substance P antibodies do not recognize CGRP, but detect several tachykinins at the immunocyto chemical level (Sundler et aI., 1985) . The sections were visualized by the use of fluorescein isothiocyanate and tetramethyl rhodamine isothiocyanate-conjugated anti rabbit IgG raised in pig. They were photographed in the fluorescence microscope using filter settings for the se lective demonstration of fluorescein isothiocyanate and tetramethyl rhodamine isothiocyanate fluorescence.
Radioimmunoassay
Cerebral vessels, choroid plexus, and dura mater were obtained from guinea pigs (n = 10), rabbits (n = 3), and cats (n = 6). The animals were decapitated under diethyl ether (guinea pig) or pentobarbital (cat) anesthesia or killed by an i. v. air injection (rabbit). Human specimens were obtained from six patients in conjunction with au topsy 24-48 h after death had occurred due to a noncere bral disorder. The tissues were removed, rapidly frozen on dry ice, and stored at a temperature of -70°C until analysis. For measurements of CGRP immunoreactivity, the material was minced and boiled in 0.9% NaCI for 10 min. The material was homogenized (Polytron, 1-2 min), centrifuged at 2000 g for 15 min, and the suspension saved. The pellet was boiled for 15 min in 0.5 M acetic acid and centrifuged at 2000 g for 15 min; this second supernatant was added to the first and lyophilized. For radioimmunoassay, the freeze-dried material was taken up in 0.05 M phosphate buffer, pH 7.4 + 0.25% HSA. CGRP was measured by radioimmunoassay using anti serum K-8429 raised in immunized rabbits. For details on the radioimmunoassay, see Grunditz et ai. (1986) . The oc currence of authentic CGRP in the pial vessels has been confirmed by reversed-phase high-performance liquid chromatography (HPLC) (Uddman et aI., 1985) .
Responses of isolated cerebral arterial segments
Rats (n = 10), guinea pigs (n = 10), rabbits (n = 12), and cats (n = 8) were killed as above. The brains were removed and the middle cerebral and/or basilar arteries dissected free and placed in a cold Krebs-Ringer solution aerated with 5% CO2 in O2, Human pial arteries were ob tained at neurosurgery in conjunction with tumor resec tions. The composition of the buffer solution was NaCI 119 mM, KCI 4.6 mM, CaCl2 1.2 mM, MgCI2 1.2 mM, NaHC03 15 mM, NH2P04 1.2 mM, and glucose 11 mM, pH 7.4.
Vessel segments, 2-3 mm long, were mounted be tween two L-shaped metal prongs in 2.5-ml mantled tissue baths kept at 37.5°C for recording of circular vaso motor activity (HogesHitt et aI., 1983) . Isometric tension was measured with Grass force-displacement transducers and recorded on a Grass polygraph. Vessel segments from human, cat, and rabbit (four studied simultaneously in parallel baths) were given a passive load of 4 mN while those of guinea pig and rat received 2 mN. The vessels were allowed to attain a steady level of tension and to accommodate in the tissue bath for 90 min before testing.
The contractile capacity of the vessels was first exam ined by exposure to an isotonic potassium-rich buffer so lution that was prepared by exchanging the NaCI in the standard buffer for KCl in equimolar amounts.
Since CGRP, calcitonin, neurokinin A and substance P induced relaxation of the vessels, each segment was given an active tone by the addition of prostaglandin F2IX (3 x 10-6 M) or 5-hydroxytryptamine (10-6 M) to the tissue bath. This resulted in a contraction that was stable for at least 30 min. During this period, the peptides were added and their capacity to relax the arteries examined.
In blockade experiments, the cholinergic blocker atro pine (10-6 M), the J3-adrenoceptor antagonist propranolol (10-7 M), the histamine H2 antagonist cimetidine (10-5 M), or the substance P antagonist spantide (10-6 M) was given 15 min before relaxation was induced by the cumu lative addition of CGRP to precontracted arteries. In other experiments designed to examine a possible inter action between substance P/neurokinin A and CGRP, substance P or neurokinin A was given 15 min prior to relaxation induced by the cumulative addition of CGRP. The concentration of substance P or neurokinin A was chosen on the basis of results from previous experiments giving a relaxation that was between 0 and 10% of max imum relaxation; for guinea pig basilar arteries, 10-1 0 M of substance P and 10-9 M of neurokinin A were given and, for rat basilar arteries, 10-9 M of substance P and 10-8 M of neurokinin A.
Data below are given as means ± SEM. Maximum di latation (ImaJ and IC 50 (concentration of agonist eliciting half-maximum relaxation) were used for comparison of the effects between various agents and antagonists. Sta tistical analysis was performed with Student's t test with appropriate Bonferroni correction.
Drugs
The following agents were used: atropine (ACO, Sweden), calcitonin gene-related peptide, rat and human variants (CRB, U.K.), calcitonin from salmon (CRB, U.K.), cimetidine (SK & F, U.K.), 5-hydroxytryptamine (Sigma, U.S.A.), neurokinin A (CRB, U.K.), propranolol (ICI, U.K.), prostaglandin F2IX (Amoglandin, Astra, Sweden), spantide (AB Ferring, Sweden), and substance P (Sigma, Sweden). The drugs were dissolved and diluted in saline just prior to experimentation. Concentrations below are given as moles per liter. The CGRP structures are given by Marshall et al. (1986b) , showing a four amino acid difference between rat and human CGRP. De tailed analysis with mass spectrometry was performed by the supplier to verify structure and purity of the material supplied.
RESULTS
Innervation of cerebral blood vessels
The immunocytochemical studies revealed in all species (guinea pig, cat, rabbit, rat, and mouse) a longitudinally oriented network of CGRP-immuno reactive nerve fibers around the large arteries be longing to, comprising, and emanating from the J Cereb Blood Flow Metab, Vol. 7, No. 6, 1987 circle of Willis (Fig. I) . Large cerebral veins were accompanied by a less dense network of CGRP-im munoreactive fibers. Few CGRP-immunoreactive fibers were seen in arterioles on the cerebral con vexity. In cross sections, the fibers were localized at the adventitia and at the adventitia-media border in all species (Fig. I) .
The density of CGRP-immunoreactive nerve fibers around cerebral arteries was comparable in all species. An overview of the nerve network in the guinea pig is presented in Fig. 2 .
Only occasional CGRP-immunoreactive fibers were seen in the dura mater of guinea pig, cat, rabbit, rat, and mouse (Fig. I) while the choroid plexus appeared to be devoid of such fibers in these species.
Removal of the superior cervical ganglion in guinea pig, rat, and mouse did not affect the number or the distribution of the cerebrovascular CGRP fibers. In the trigeminal ganglion numerous CGRP-immunoreactive nerve cell bodies were seen. Double immunostaining revealed that CGRP coexisted with SP in the majority of the CGRP-con taining cell bodies in the trigeminal ganglion and in perivascular nerve fibers around pial blood vessels (Fig. 3) .
Radioimmunoassay of CGRP
The concentrations of CGRP in cerebrovascular tissues are presented in Ta ble 1. The levels of the peptide compare well with the number of CGRP fibers observed by immunocytochemistry. The CGRP levels of various cerebral arteries were ana lysed further in feline vessels (not shown). It was noted that higher levels were seen in the middle ce rebral artery than in the basilar artery and pial arte rioles from the cerebral convexity.
Measurable levels of CGRP were not observed in the choroid plexus and dura mater of many species, except in the cat, where low levels of CGRP were present ( Table I) .
Vasomotor responses of isolated cerebral arteries
Rat CGRP effected concentration-dependent re laxation of precontracted cerebral arterial segments from all species examined (human pial, cat middle cerebral, rabbit basilar, guinea pig basilar, and rat basilar arteries). The concentration of rat CGRP eliciting half-maximal response was smallest in human pial arteries (0.37 ± 0. 15 nM) and greatest in the rabbit and rat basilar arteries (3 nM). Almost complete relaxation of the pre contracted arteries was observed with rat CGRP in all species with the exception of the rabbit basilar artery where the maximum relaxation was 55 ± 9% of the precon traction ( Table 2) .
The vasomotor effects of human CGRP and rat CGRP were compared in human pial arteries. Human CGRP and rat CGRP differ in four of the 37 amino acids (Amara et al., 1982; Morris et al. , 1984) . In terms of the con centrations eliciting half-maximal response, human CGRP was approximately six times more potent than rat CGRP in eliciting relaxation of human pial arteries. The maximal responses of human pial ar teries to human CGRP and rat CGRP were similar (Fig. 4A) . Salmon calcitonin, a 32 amino acid pep tide with little structural homology with rat CGRP, elicited relaxations of human pial and guinea pig basilar arteries. However, the maximum response was smaller (� 1O% of the precontraction) and the concentrations of calcitonin for half-maximal re sponse higher (�300 nM) than for rat CORP (Fig.  4A and B) . The vasorelaxant effect of rat CORP in guinea pig basilar arteries was not potentiated by the pres ence in the bath of substance P (0. 1 nM) or neuro kinin A (3 nM). The concentration of tachykinins is the maximum concentration that does not induce relaxation of cerebral vessels per se. In the pres ence of neurokinin A, the maximum response to rat CORP was considerably reduced (Fig. 5) . The pres ence in the bath of atropine (10-6 M), cimetidine (10-6 M), propranolol (10-7 M), or spantide (10-6 M) did not modify the relaxant effects of rat CORP in the guinea pig basilar or the cat middle cerebral artery.
DISCUSSION
The present immunocytochemical studies have revealed that various parts of the cerebrovascular bed are supplied with CORP-immunoreactive peri vascular fibers. As shown for the cat, the CORP levels were significantly higher in the major cere bral arteries of the circle of Willis than in pial vessels on the cerebral convexities. Only few CORP fibers were seen in the dura mater while the J Cereb Blood Flow Metab. Vol. 7. No.6, 1987 choroid plexus seemed to lack CORP fibers. Thus, the concentrations of CORP encountered in cere bral vessels, choroid plexus, and dura mater corre lated well with the density of the immunoreactive fibers.
Numerous CORP-containing nerve cell bodies were found within the trigeminal ganglion. Double immunostaining revealed the co-existence of sub stance P and CORP in a subpopulation of cell bodies of the trigeminal ganglion and in pial blood vessels. Lesion studies confirmed that the origin of most of the cerebrovascular CORP-and substance P-immunoreactive nerve fibers was in the trigem inal ganglion since both peptides disappeared 1-2 weeks after sectioning the trigeminal nerve distal to the trigeminal ganglion as shown by radioimmuno assay and immunocytochemistry (Uddman et aI., 1985) . It is of interest to note that the cerebrovas cular fibers originate in trigeminal neurons which colocate CORP/substance P while trigeminal neu rons lacking substance P distribute to the iris (Mat suyama et aI., 1986) .
In view of the known coexistence of substance P and CORP in sensory neurons (Sundler et aI., 1985; Oibbins et aI., 1985; Lundberg et aI., 1985) , it is tempting to suggest that the cerebrovascular sub stance P/CORP nerve fibers are sensory, and that the two peptides cooperate at the neuroeffector junction. The evidence in support of their involve ment in nociception are: (a) capsaicin causes a re duction in perivascular peptide concentrations (Duckles and Buck, 1982; Saito and Ooto, 1986; Wharton et aI., 1986) ; (b) Their trigeminal origin (Liu-Chen et aI., 1983; Uddman et aI., 1985) ; and (c) the distribution with low levels in convexity vessels and higher levels in major cerebral arteries. This observation correlates well with the classic studies by Ray and Wolff (1940) , who demonstrated that the larger arteries were sensitive and the arte rioles insensitive to noxious stimuli in humans.
CORP fibers have been found throughout the car diovascular system (Mulderry et aI., 1985; Uddman et aI., 1986; Wharton et aI., 1986) . CORP has been isolated from both rats (Amara et aI., 1982; Rosen feld et aI., 1983) and humans (Morris et aI., 1984) . The direct effect of CORP is to induce dilatation of isolated blood vessels (Brain et aI., 1985; Ed vinsson et aI., 1985; Hanko et aI., 1985; U ddman et aI., 1986) . Even though there is a difference in four of the amino acids, human CORP was more potent than rat CORP when tested on human pial vessels. In vessels from the various mammals, calcitonin was always considerably less effective than CORP, both in potency and efficacy. The maximum re laxant effect of calcitonin was not achieved in all tests since sometimes very high concentrations of calcitonin were necessary. This is in accord with studies on isolated mesenteric vascular prepara tions from rat and rabbit in which human and salmon calcitonin evoked only very weak dilator responses (Marshall et aI., 1986a) . CGRP, sub stance P, and neurokinin A lower mean arterial blood pressure in the guinea pig (Lundberg et al. , 1985) . As vasodepressor agents in the pithed rat, CGRP is about ten times more potent than sub stance P (Haass and Skofitsch, 1985) . Administra tion of CGRP in situ causes dilatation of cerebral arteries and arterioles, but not of cerebral veins as studied in cats McCulloch et al. , 1986) . The CGRP-evoked vasodilatation is not mediated by adrenergic, cholinergic, histamin ergic or substance P receptors (present results). The relaxation has been suggested to be mediated via the release of an endothelial-dependent relaxing factor as noted in the guinea pig aorta (Brain et aI. , 1985) while studies on brain vessels have shown that these vessels do not appear to display an endo thelium dependency, i.e., CGRP causes equally strong dilatation whether or not the endothelium is present (Edvinsson et aI., 1985; Hanko et aI., 1985) . The relaxation occurs in the same concentrations as those that cause activation of cerebrovascular adenylate cyclase (Edvinsson et aI. , 1985) . The ef fect of CGRP has been suggested to be primarily post junctional since, at least in the rat vas deferens, the peptide does not modify the uptake or release of 3H-noradrenaline following electrical field stimu lation (AI-Kazwini et aI. , 1986). In rat skin, administration of substance P and neurokinin A may cause extravasation of plasma proteins (Gamse and Saria, 1985) . CGRP, which in itself is without effect, enhanced the extravasation induced by substance P and neurokinin A. This was thought to be due to a local vasodilatation. In the present experiments, the CGRP-induced relaxant responses of guinea pig basilar arteries were not Values given are means ± SEM; n = number of vessel seg ments analyzed. pOz = negative logarithm of the concentration of CGRP that causes half-maximum relaxation. Im• x = max imum relaxation of precontraction induced by 3 x 10-6 M PGFZa or, for rat basilar arteries, 10-5 M 5-hydroxytryptamine. potentiated by the previous addition of substance P or neurokinin A. Conversely, tachykinin-induced relaxations were not affected by a prior CGRP ad ministration (unpublished data). Thus, the three coexisting peptides do not appear to modulate the effects of one another. However, they induce relax ation respectively via CGRP or tachykinin re ceptors ; the effects thus appear synergistic on the vessel. 
